Validation of Diagnostic Codes for Identifying Chlamydial Infections From TriNetX Electronic Health Record Data in the United States
Sponsor: Sanofi
Trial Details
| Condition | Chlamydial Infections |
| Status | Recruiting |
| Participants | 533,000 |
| Est. Completion | 31 Aug 2026 |
| Last Updated | 10 July 2026 |
Primary Outcome
Validity of ICD-10-CM Diagnostic Codes for Chlamydial Infections; Descriptive analyses of chlamydia patients
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria for Primary Objectives: * Patients with an ICD-10-CM diagnosis of chlamydia documented in their EHR OR patients with a nucleic acid amplification test (NAAT) result for chlamydia (either positive or negative) during the study period. The index date is the date of the first-recorded diagnosis code, or the date of the first-recorded NAAT result when no diagnosis code for chlamydia exists. * Patients with at least one visit within 30 days both before and after their index date. Exclusion Criteria for Primary Objectives: * Patients with no documented ICD-10-CM diagnosis for chlamydia who possessed unknown laboratory test results for chlamydia during the study period (removed from ICD validation assessment in primary analysis). * Patients with an ICD-10-CM diagnosis without a corresponding laboratory test (removed from ICD validation assessment in primary analysis). Note: The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service